An interlocker concept of carcinogenesis

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 8, 2006, Pages 1425-1426

  Wattenberg, Lee W ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLGLUCOSAMINIDASE; ACETYLGLUCOSAMINIDASE V; GLYCOPROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

CARCINOGENESIS; CELL INFILTRATION; CELL PROLIFERATION; CHEMOPROPHYLAXIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBLICATION; REVIEW;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CONCEPT FORMATION; HUMANS; NEOPLASMS;

EID: 33748032691     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0326     Document Type: Review

References (24)

1. Dennis JW, Laferte S. Oncodevelopmental expression of-GlcNAc β1-6Man α1-6Man β1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 1989;49:945-50.
2. Fernandes B, Sagman U, Auger M, et al. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 1991;51:718-23.
3. Seelentag WK, Li WP, Schmitz SF, et al. Prognostic value of β1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 1998;58:5559-64.
4. Lu Y, Pelling JC, Chaney WG. Tumor cell surface β1-6 branched oligosaccharides and lung metastasis. Clin Exp Metastasis 1994;12:47-54.
5. Dosaka-Akita H, Miyoshi E, Suzuki O, et al. Expression of N-acetylglucosaminyltransferase V is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res 2004;10:1773-9.
6. Takano R, Nose M, Nishihira T, et al. Increase of β1-6-branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am J Pathol 1990;137:1007-11.
7. Ochwat D, Hoja-Lukowicz D, Litynska A. N-glycoproteins bearing β1-6 branched oligosaccharides from the A375 human melanoma cell line analysed by tandem mass spectrometry. Melanoma Res 2004;14:479-85.
8. Kobata A, Amano J. Altered glycosylation of proteins produced by malignant cells, and application for the diagnosis and immunotherapy of tumours. Immunol Cell Biol 2005;83:429-39.
9. Dennis JW, Laferte S, Waghorne C, et al. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-5.
10. Miyoshi E, Nishikawa A, Ihara Y, et al. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 1993;53:3899-902.
11. Yanagi M, Aoyagi Y, Suda T, et al. N-acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J Gastroenterol Hepatol 2001;16:1282-9.
12. Takahashi T, Hagisawa S, Yoshikawa K, et al. Predictive value of N-acetylglucosaminyltransferase-V for superficial bladder cancer recurrence. J Urol 2006;175:90-3; discussion 3.
13. Granovsky M, Fata J, Pawling J, et al. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 2000;6:306-12.
14. Korczak B, Le T, Elowe S, et al. Minimal catalytic domain of N-acetylglucosaminyltransferase V. Glycobiology 2000;10:595-9.
15. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002;36:115-24.
16. Bremnes RM, Veve R, Gabrielson E, et al. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J Clin Oncol 2002;20:2417-28.
17. Kato Y, Hirano T, Yoshida K, et al. Frequent loss of E-cadherin and/or catenins in intrabronchial lesions during carcinogenesis of the bronchial epithelium. Lung Cancer 2005;48:323-30.
18. Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005;17:499-508.
19. Pierceall WE, Woodard AS, Morrow JS, et al. Frequent alterations in E-cadherin and α- and β-catenin expression in human breast cancer cell lines. Oncogene 1995;11:1319-26.
20. Doki Y, Shiozaki H, Tahara H, et al. Correlation between E-cadherin expression and invasiveness in vitro in a human esophageal cancer cell line. Cancer Res 1993;53:3421-6.
21. Perl AK, Wilgenbus P, Dahl U, et al. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998;392:190-3.
22. Calvisi DF, Ladu S, Conner EA, et al. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab Invest 2004;84:1137-47.
23. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993;262:1734-7.
24. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000;87:992-1005.